XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Instruments
9 Months Ended
Sep. 30, 2023
Financial Instruments Disclosure [Abstract]  
Financial Instruments
4.
Financial Instruments

Our financial assets are measured at fair value on a recurring basis using the following hierarchy to prioritize valuation inputs, in accordance with applicable U.S. GAAP:

Level 1: Quoted prices in active markets for identical assets or liabilities that we have the ability to access

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data such as quoted prices, interest rates and yield curves

Level 3: Inputs that are unobservable data points that are not corroborated by market data

We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels of certain securities within the fair value hierarchy. We recognize transfers into and out of levels within the fair value hierarchy in the period in which the actual event or change in circumstances that caused the transfer occurs. There have been no transfers between Level 1, Level 2 and Level 3 in any periods presented.

Financial assets and liabilities are considered Level 2 when their fair values are determined using inputs that are observable in the market or can be derived principally from or corroborated by observable market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and benchmark securities. In addition, Level 2 financial instruments are valued using comparisons to like-kind financial instruments and models that use readily observable market data as their basis. U.S. Treasury, government agency and corporate debt obligations, commercial paper and asset-backed securities are valued primarily using market prices of comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level 2.

Financial assets and liabilities are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies, or similar techniques, and at least one significant model assumption or input is unobservable. We have no Level 3 financial assets or liabilities.

The following tables summarize the estimated fair value and related valuation input hierarchy of our available-for-sale securities as of each period end:

 

 

 

 

Total

 

 

Total

 

 

Total

 

 

Total

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

As of September 30, 2023:

 

Input Level

 

Cost

 

 

Gain

 

 

Loss

 

 

Fair Value

 

 

 

 

 

(in thousands)

 

Money market funds

 

Level 1

 

$

35,230

 

 

$

 

 

$

 

 

$

35,230

 

U.S. Treasury obligations

 

Level 2

 

 

28,318

 

 

 

4

 

 

 

 

 

$

28,322

 

Government agency obligations

 

Level 2

 

 

1,451

 

 

 

 

 

 

(26

)

 

$

1,425

 

Corporate debt obligations

 

Level 2

 

 

34,018

 

 

 

 

 

 

(509

)

 

$

33,509

 

Asset-backed securities

 

Level 2

 

 

2,723

 

 

 

 

 

 

(40

)

 

$

2,683

 

Total available-for-sale securities

 

 

 

 

101,740

 

 

 

4

 

 

 

(575

)

 

 

101,169

 

Less: amounts classified as cash equivalents

 

 

 

 

(63,548

)

 

 

(4

)

 

 

 

 

 

(63,552

)

Amounts classified as short-term investments

 

 

 

$

38,192

 

 

$

 

 

$

(575

)

 

$

37,617

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

Total

 

 

Total

 

 

Total

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

As of December 31, 2022:

 

Input Level

 

Cost

 

 

Gain

 

 

Loss

 

 

Fair Value

 

 

 

 

 

(in thousands)

 

Money market funds

 

Level 1

 

$

78,033

 

 

$

 

 

$

 

 

$

78,033

 

U.S. Treasury obligations

 

Level 2

 

 

63,013

 

 

 

3

 

 

 

(394

)

 

 

62,622

 

Government agency obligations

 

Level 2

 

 

8,086

 

 

 

 

 

 

(48

)

 

 

8,038

 

Corporate debt obligations

 

Level 2

 

 

82,598

 

 

 

4

 

 

 

(1,513

)

 

 

81,089

 

Commercial paper

 

Level 2

 

 

996

 

 

 

 

 

 

 

 

 

996

 

Asset-backed securities

 

Level 2

 

 

6,343

 

 

 

 

 

 

(119

)

 

 

6,224

 

Total available-for-sale securities

 

 

 

 

239,069

 

 

 

7

 

 

 

(2,074

)

 

 

237,002

 

Less: amounts classified as cash equivalents

 

 

 

 

(87,122

)

 

 

(3

)

 

 

 

 

 

(87,125

)

Amounts classified as short-term investments

 

 

 

$

151,947

 

 

$

4

 

 

$

(2,074

)

 

$

149,877

 

The amortized cost and fair value of our available-for-sale securities by contractual maturity were as follows:

 

As of September 30, 2023

 

 

As of December 31, 2022

 

 

Amortized

 

 

Estimated

 

 

Amortized

 

 

Estimated

 

 

Cost

 

 

Fair Value

 

 

Cost

 

 

Fair Value

 

 

(in thousands)

 

 

(in thousands)

 

Maturing within one year

$

97,367

 

 

$

96,863

 

 

$

202,323

 

 

$

201,359

 

Maturing in one to five years

 

4,373

 

 

 

4,306

 

 

 

36,746

 

 

 

35,643

 

Total available-for-sale securities

$

101,740

 

 

$

101,169

 

 

$

239,069

 

 

$

237,002

 

We considered the current and expected future global economic and market conditions, including, but not limited to, the wars in Ukraine and the Middle East and increased tensions between the U.S. and China, and determined that our investments have not been significantly impacted. As of September 30, 2023, no significant facts or circumstances were present to indicate a deterioration in the creditworthiness of the issuers of the available-for-sale securities we hold, and we have no requirement or intention to sell these securities before maturity or recovery of their amortized cost basis. For all securities with a fair value less than its amortized cost basis, we determined the decline in fair value below amortized cost basis to be non-credit related and no allowance for losses has been recorded. During the three and nine months ended September 30, 2023 and 2022, we did not recognize any impairment losses on our investments.

We have elected the practical expedient to exclude the applicable accrued interest from both the fair value and the amortized cost basis of our available-for-sale securities for purposes of identifying and measuring an impairment. We present accrued interest receivable related to our available-for-sale securities in other current assets, separate from short-term investments, on our condensed consolidated balance sheet. As of September 30, 2023 and December 31, 2022, accrued interest receivable was $0.4 million and $0.8 million, respectively. We have not written off any accrued interest receivables during the three and nine months ended September 30, 2023 and 2022.

In addition, restricted cash collateralized by money market funds is a financial asset measured at fair value and is a Level 1 financial instrument under the fair value hierarchy.

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same such amounts in the condensed consolidated statement of cash flows:

 

 

September 30,

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Cash and cash equivalents

 

$

64,791

 

 

$

92,942

 

Restricted cash – short term

 

 

146

 

 

 

146

 

Total cash, cash equivalents and restricted cash

 

$

64,937

 

 

$

93,088